Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | CES1 | P23141 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.55 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.55 |
| ▸ | FEN1 | P39748 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11373627 | 0.89 | KMT2A (0.73) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| Benzene SCHEMBL8209405 | 0.89 | KMT2A (0.73) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL15116 | 0.89 | KMT2A (0.73) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| Hydrogen Peroxide SCHEMBL28455182 | 0.89 | KMT2A (0.73) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL1977011 | 0.89 | KMT2A (0.80) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL3201635 | 0.87 | KMT2A (0.70) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL21597904 | 0.87 | KMT2A (0.70) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL21597902 | 0.87 | KMT2A (0.70) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL3071951 | 0.87 | KMT2A (0.70) | KMT2AMEN1CYP3A4HPGDMAPK1 | |
| SCHEMBL6319140 | 0.87 | KMT2A (0.70) | KMT2AMEN1CYP3A4HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5877210-A | CONTROLLING IMMUNE RESPONSE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-02 | — | — | US | claimed |
| US-5583242-A | VANADYL COMPLEXES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| US-5565491-A | FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | GENOMATICA INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250290048-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | CREO INGREDIENTS, INC. | 2025-09-18 | — | — | US | disclosed |
| US-20250179541-A1 | METHOD OF PRODUCING CANNABINOIDS | CREO INGREDIENTS, INC. | 2025-06-05 | — | — | US | disclosed |
| US-20230332193-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | CREO INGREDIENTS, INC. | 2023-10-19 | — | — | US | disclosed |
| US-20230241078-A1 | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | CFM PHARMA HOLDING B.V. (NL) | 2023-08-03 | — | — | US | disclosed |
| CN-113631136-A | Primer and kit of primer and dental material | 凯滕巴赫股份两合公司 | 2021-11-09 | — | — | CN | disclosed |
| US-20200246352-A1 | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | CFM PHARMA HOLDING B.V. (NL) | 2020-08-06 | — | — | US | disclosed |
| EP-3684352-A1 | VANADYL AND VANADATE FOR USE IN REDUCING STRESS -INDUCED METABOLIC DERANGEMENT | CFM Pharma Holding BV (NL) | 2020-07-29 | — | — | EP | disclosed |
| WO-1995020390-A1 | USE OF VANADIUM MOLYBDENUM OR TUNGSTEN COMPLEXES FOR CONTROLLING CELLULAR PROLIFERATION | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-08-03 | — | — | WO | disclosed |
| EP-0031637-B1 | IMPROVEMENTS IN OR RELATING TO FILLED POLYMERIC COMPOSITIONS, HYDRATED ALUMINA FILLERS THEREFOR AND PROCESSES FOR THE PRODUCTION THEREOF | RAYCHEM LIMITED (GB) | 1984-10-03 | — | — | EP | disclosed |
| US-4396589-A | Alkali metal complex compounds, and their use in the hydrogenation and nitridation of alkali metals | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1983-08-02 | — | — | US | disclosed |
| US-4382983-A | PARTIALLY HYDROLYZED SILOXANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-05-10 | — | — | US | disclosed |
| US-4370488-A | CATALYSTS FOR HYDROGENATION OF ALFALI METALS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1983-01-25 | — | — | US | disclosed |
| US-4330637-A | Encapsulated electronic devices and encapsulating compositions | WESTERN ELECTRIC COMPANY, INC. (US) | 1982-05-18 | — | — | US | disclosed |
| US-4301081-A | FOR USE AS CATALYST FOR HYDROGENATION OF ALKALI METALS TO HYDRIDES OR NITRIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1981-11-17 | — | — | US | disclosed |
| EP-0031637-A2 | Improvements in or relating to filled polymeric compositions, hydrated alumina fillers therefor and processes for the production thereof | RAYCHEM LIMITED (GB) | 1981-07-08 | — | — | EP | disclosed |
| US-4229354-A | COMPLEXING WITH COMPOUNDS OF SULFUR OR OXYGEN | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1980-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388874-A1 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | BLVRB, SQOR, CYP2F1 | KMT2A 3075/4885MEN1 3893/4885CYP3A4 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.